Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHA:600613)

China flag China · Delayed Price · Currency is CNY
4.910
+0.050 (1.03%)
Jul 31, 2026, 3:00 PM CST
Market Cap2.52B -29.7%
Revenue (ttm)1.90B -3.0%
Net Income36.13M -42.1%
EPS0.06 -47.9%
Shares Out 534.07M
PE Ratio79.15
Forward PEn/a
Dividend0.07 (1.43%)
Ex-Dividend DateJun 17, 2026
Volume8,435,507
Open4.860
Previous Close4.860
Day's Range4.820 - 4.920
52-Week Range4.330 - 7.530
Beta0.41
Analystsn/a
Price Targetn/a
Earnings DateAug 29, 2026

About SHA:600613

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., together with its subsidiaries, operates as a pharmaceutical manufacturing holding investment company in China. The company engages in the research and development, and production of anti-tumor, cardiovascular, cerebrovascular, rheumatism bone pain, tonic and sedative, cold and cough, anti-fungal, gynecology, and other treatment fields. Its products include prescription drugs and OTC products, including products include sodium cantharidate vitamin B6 injection, sodium cantharidin i... [Read more]

Sector Healthcare
Founded 1990
Employees 1,196
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600613
Full Company Profile

Financial Performance

In 2025, SHA:600613's revenue was 1.95 billion, a decrease of -4.71% compared to the previous year's 2.05 billion. Earnings were 38.24 million, a decrease of -46.43%.

Financial Statements